KRAS and cardiofaciocutaneous syndrome 1: This molecular finding could have prompted a reassessment of the phenotype and in some cases could lead to the alternative diagnosis of CFCS since BRAF, and also KRAS, are considered an NS and CFCS gene by OMIM (NS7/CFCS1 and NS3/CFCS2, respectively) [8,23].